Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $109.3700 (-1.91%) ($109.3700 - $109.3700) on Wed. Aug. 4, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.37% (three month average) | RSI | 45 | Latest Price | $109.3700(-1.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -2.5% a day on average for past five trading days. | Weekly Trend | LGND declines -3.1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(56%) IWC(53%) IWN(51%) | Factors Impacting LGND price | LGND will decline at least -1.185% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-17%) UNG(-4%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.185% (StdDev 2.37%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $119.46 | 5 Day Moving Average | $112.73(-2.98%) | 10 Day Moving Average | $117.11(-6.61%) | 20 Day Moving Average | $119.46(-8.45%) | To recent high | -20.4% | To recent low | 0% | Market Cap | $1.758b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |